Provided by Tiger Trade Technology Pte. Ltd.

Bio-Rad Laboratories

265.40
-11.1300-4.02%
Post-market: 265.400.00000.00%17:18 EDT
Volume:339.74K
Turnover:90.51M
Market Cap:7.16B
PE:9.53
High:276.51
Open:276.51
Low:264.23
Close:276.53
52wk High:343.12
52wk Low:211.43
Shares:26.97M
Float Shares:18.51M
Volume Ratio:0.83
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.85
EPS(LYR):27.85
ROE:10.84%
ROA:1.67%
PB:0.96
PE(LYR):9.53

Loading ...

Bell Potter Keeps Their Buy Rating on Biome Australia Ltd (BIO)

TIPRANKS
·
Jan 28

KALA BIO Receives Nasdaq Notice on Listing Compliance

TIPRANKS
·
Jan 24

Qiagen Explores Possible Sale After New Buyer Talks: Report

Benzinga_recent_news
·
Jan 21

Lendable Breaks New Ground in Impact Fund Raise

prnewswire
·
Jan 21

Horizon Space Updates Proxy Materials for SL BIO Merger

TIPRANKS
·
Jan 16

Dalian BIO-CHEM Elects Chair

MT Newswires Live
·
Jan 15

SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination

GlobeNewswire
·
Jan 14

KALA BIO Launches At-the-Market Equity Offering Program

TIPRANKS
·
Jan 09

Press Release: SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Dow Jones
·
Jan 07

Bio-Rad Laboratories Executives Meet Investors at J.P. Morgan Healthcare Conference

Reuters
·
Jan 06

New crypto tokens are failing in 2025: 85% below TGE prices

cryptonews
·
Dec 21, 2025

First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D

GlobeNewswire
·
Dec 18, 2025

SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D

GlobeNewswire
·
Dec 17, 2025

BIO-key Answers the Call for Secure, Modern Authentication with New Passwordless Innovations at the 2025 Gartner® IAM Summit: North America

GlobeNewswire
·
Dec 08, 2025

SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management

GlobeNewswire
·
Dec 08, 2025

KALA BIO Raises $10 Million From Direct Offering

MT Newswires Live
·
Dec 06, 2025

Press Release: KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Dow Jones
·
Dec 04, 2025

Why Did KALA BIO Shares Jump Over 22% After Hours?

Benzinga_recent_news
·
Dec 04, 2025

Biome Australia Limited's (ASX:BIO) Price In Tune With Revenues

Simply Wall St.
·
Dec 02, 2025

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

GlobeNewswire
·
Dec 01, 2025